Tharimmune Inc (NAS:THAR)
$ 2.08 -0.18 (-7.96%) Market Cap: 3.09 Mil Enterprise Value: 82,000.00 PE Ratio: 0 PB Ratio: 0.89 GF Score: 21/100

Hillstream BioPharma Inc to Host Virtual R&D Day Transcript

Feb 14, 2023 / 03:00PM GMT
Release Date Price: $697.5 (-1.59%)
Operator

Recorded. I would now like to turn the conference over to your host, Randy Milby, Chief Executive Officer. Hillstream. Please go ahead.

Randy Milby
Hillstream BioPharma, Inc. - CEO & Chairman

Thank you. Welcome, everyone. I'm very excited to share some of our recent collaborations with you today.

Before we get started, though, like to address the -- we will be making some forward-looking statements. You can also check this out on our website, www.hillstreambio.com.

We have a great agenda for you today. I'll kick it off with talking about a little bit on our milestones, and then Don Kufe will talk about targeting MUC1-C, and then Dr. Smider Vaughn will talk about targeted biologics. And then I'll go into a little more in the future directions.

Before we get started, though, there's a common theme on some of these collaborations that we've done and that's to improve -- our mission is to improve and transform the lives of patients with drug-resistant and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot